Literature DB >> 15863717

Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?

Barry I Hudson, Evis Harja, Bernhard Moser, Ann Marie Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15863717     DOI： 10.1161/01.ATV.0000164804.05324.8b

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  29 in total

1.  Rutin Inhibits Neuroinflammation and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage, Possibly Through Suppressing the RAGE-NF-κB Inflammatory Signaling Pathway.

Authors:  Guangzhi Hao; Yushu Dong; Rentao Huo; Kai Wen; Yinsong Zhang; Guobiao Liang
Journal:  Neurochem Res       Date:  2016-02-11       Impact factor: 3.996

2.  Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction.

Authors:  Erick D McNair; Calvin R Wells; A M Qureshi; Colin Pearce; Gudrun Caspar-Bell; Kailash Prasad
Journal:  Int J Angiol       Date:  2011-03

3.  Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients.

Authors:  Erick D McNair; Calvin R Wells; A Mabood Qureshi; Rashpal S Basran; Colin Pearce; Jason Orvold; Jacobus Devilliers; Kailash Prasad
Journal:  Int J Angiol       Date:  2009

4.  Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.

Authors:  Bo Feng; Lei Xu; Hua Wang; Xinfeng Yan; Junli Xue; Fengjing Liu; Ji-Fan Hu
Journal:  Biochim Biophys Acta       Date:  2011-05-30

5.  Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

Authors:  K C B Tan; S W M Shiu; W S Chow; L Leng; R Bucala; D J Betteridge
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

6.  Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.

Authors:  Richard D Semba; Luigi Ferrucci; Kai Sun; Justine Beck; Mansi Dalal; Ravi Varadhan; Jeremy Walston; Jack M Guralnik; Linda P Fried
Journal:  Aging Clin Exp Res       Date:  2009-04       Impact factor: 3.636

7.  Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.

Authors:  Hidenori Koyama; Hiroshi Yamamoto; Yoshiki Nishizawa
Journal:  Biomark Insights       Date:  2007-09-17

8.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

9.  Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.

Authors:  Richard D Semba; Luigi Ferrucci; Jeffrey C Fink; Kai Sun; Justine Beck; Mansi Dalal; Jack M Guralnik; Linda P Fried
Journal:  Am J Kidney Dis       Date:  2008-09-11       Impact factor: 8.860

10.  Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.

Authors:  Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Yayoi Kurita-Nakamura; Takanori Matsui; Takafumi Yoshida; Tsutomu Imaizumi
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.